146 related articles for article (PubMed ID: 27449854)
1. Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Salapa H
J Neuroimmunol; 2017 Mar; 304():56-62. PubMed ID: 27449854
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.
Lee SM; Dunnavant FD; Jang H; Zunt J; Levin MC
Neurosci Lett; 2006 Jun; 401(1-2):188-93. PubMed ID: 16600502
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.
Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC
J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740
[TBL] [Abstract][Full Text] [Related]
4. HTLV-1 induced molecular mimicry in neurological disease.
Lee SM; Morcos Y; Jang H; Stuart JM; Levin MC
Curr Top Microbiol Immunol; 2005; 296():125-36. PubMed ID: 16323422
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
Douglas JN; Gardner LA; Salapa HE; Lalor SJ; Lee S; Segal BM; Sawchenko PE; Levin MC
J Neuroinflammation; 2016 Jul; 13(1):178. PubMed ID: 27391474
[TBL] [Abstract][Full Text] [Related]
6. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease.
Jernigan M; Morcos Y; Lee SM; Dohan FC; Raine C; Levin MC
Neurology; 2003 Apr; 60(8):1320-7. PubMed ID: 12707436
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Groover CJ
Degener Neurol Neuromuscul Dis; 2012; 2():175-187. PubMed ID: 30890887
[TBL] [Abstract][Full Text] [Related]
8. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
Osame M
J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity due to molecular mimicry as a cause of neurological disease.
Levin MC; Lee SM; Kalume F; Morcos Y; Dohan FC; Hasty KA; Callaway JC; Zunt J; Desiderio D; Stuart JM
Nat Med; 2002 May; 8(5):509-13. PubMed ID: 11984596
[TBL] [Abstract][Full Text] [Related]
10. Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Yukitake M; Sueoka E; Sueoka-Aragane N; Sato A; Ohashi H; Yakushiji Y; Saito M; Osame M; Izumo S; Kuroda Y
J Neurovirol; 2008 Apr; 14(2):130-5. PubMed ID: 18444084
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
12. Antibody transfection into neurons as a tool to study disease pathogenesis.
Douglas JN; Gardner LA; Lee S; Shin Y; Groover CJ; Levin MC
J Vis Exp; 2012 Sep; (67):. PubMed ID: 23051967
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity and molecular mimicry in tropical spastic paraparesis/human T-lymphotropic virus-associated myelopathy.
García-Vallejo F; Domínguez MC; Tamayo O
Braz J Med Biol Res; 2005 Feb; 38(2):241-50. PubMed ID: 15785836
[TBL] [Abstract][Full Text] [Related]
14. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
[TBL] [Abstract][Full Text] [Related]
15. Human T-cell lymphotropic virus type I and neurological diseases.
Nagai M; Osame M
J Neurovirol; 2003 Apr; 9(2):228-35. PubMed ID: 12707853
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Yamano Y; Sato T
Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
[TBL] [Abstract][Full Text] [Related]
17. Neuronal molecular mimicry in immune-mediated neurologic disease.
Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
[TBL] [Abstract][Full Text] [Related]
18. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections].
Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F
Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
